View Item 

Show simple item record

Determination of Fluoxetine and Norfluoxetine Concentrations in Cadaveric Allograft Skin

dc.contributor.authorNeudeck, Brien L.en_US
dc.contributor.authorTaddonio, Thomas E.en_US
dc.contributor.authorGarner, Warren L.en_US
dc.contributor.authorWelage, Lynda S.en_US
dc.date.accessioned2012-03-16T15:55:25Z
dc.date.available2012-03-16T15:55:25Z
dc.date.issued1998-07-08en_US
dc.identifier.citationNeudeck, Brien L.; Taddonio, Thomas E.; Garner, Warren L.; Welage, Lynda S. (1998). "Determination of Fluoxetine and Norfluoxetine Concentrations in Cadaveric Allograft Skin." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 18(4). <http://hdl.handle.net/2027.42/90146>en_US
dc.identifier.issn0277-0008en_US
dc.identifier.issn1875-9114en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90146
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.titleDetermination of Fluoxetine and Norfluoxetine Concentrations in Cadaveric Allograft Skinen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumSection of Plastic Surgery, University of Michigan Health Systems, Ann Arbor, Michigan.en_US
dc.contributor.affiliationumDepartment of Pharmacy, University of Michigan Health Systems, Ann Arbor, Michigan.en_US
dc.contributor.affiliationumUniversity of Michigan College of Pharmacy, Ann Arbor, Michigan.en_US
dc.contributor.affiliationumUniversity of Michigan Skin Bank, University of Michigan Health Systems, Ann Arbor, Michigan.en_US
dc.identifier.pmid9692660en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90146/1/j.1875-9114.1998.tb03908.x.pdf
dc.identifier.doi10.1002/j.1875-9114.1998.tb03908.xen_US
dc.identifier.sourcePharmacotherapy: The Journal of Human Pharmacology and Drug Therapyen_US
dc.identifier.citedreferenceBenfield P, Heel RC, Lewis SP. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in depressive illness. Drugs 1986; 32: 481 – 508.en_US
dc.identifier.citedreferenceBarratt GE, Koopmann CF Jr. Skin grafts: physiology and clinical considerations. Otolaryngol Clin North Am 1984; 17: 335 – 51.en_US
dc.identifier.citedreferencePuopolo PR, Volpicelli SA, Johnson DM, Flood JG. Emergency toxicology testing (detection, confirmation, and quantification) of basic drugs in serum by liquid chromatography with photodiode array detection. Clin Chem 1991; 37: 2124 – 30.en_US
dc.identifier.citedreferenceRoettger JR. The importance of blood collection site for the determination of basic drugs: a case with fluoxetine and diphenhydramine overdose [letter]. J Anal Toxicol 1990; 14: 191 – 2.en_US
dc.identifier.citedreferenceRohrig TP, Prouty RW. Fluoxetine overdose: a case report. J Anal Toxicol 1989; 13: 305 – 7.en_US
dc.identifier.citedreferenceKincaid RL, McMullin MM, Crookham SB, Rieders F. Report of a fluoxetine fatality. J Anal Toxicol 1990; 14: 327 – 9.en_US
dc.identifier.citedreferenceAnderson WH, Prouty RW. Postmortem redistribution of drugs. In: Baselt RC, ed. Advances in analytical toxicology, vol II. Chicago: Year Book, 1989: 70 – 102.en_US
dc.identifier.citedreferenceJones GR, Pounder DJ. Site dependence of drug concentrations in postmortem blood—a case study. J Anal Toxicol 1987; 11: 186 – 90.en_US
dc.identifier.citedreferenceWashington C, Washington N. Drug delivery to the skin. In: Wilson CG, Washington N, eds. Physiological pharmaceutics: biological barriers to drug absorption. New York: Halstead Press, 1989: 109 – 20.en_US
dc.identifier.citedreferencePierce GA, Graham WK, Kaufman HM Jr, Wolf JS. The united network for organ sharing: 1984–1994. Transplant Proc 1996; 28: 12 – 15.en_US
dc.identifier.citedreferenceBennie EH, Mullin JM, Martindale JJ. A double‐blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression. J Clin Psychiatry 1995; 56: 229 – 37.en_US
dc.identifier.citedreferenceCohn JB, Collins G, Ashbrook E, Wernicke JF. A comparison of fluoxetine, imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989; 4: 313 – 22.en_US
dc.identifier.citedreferenceTollefson GD, Rampey AH Jr, Potvin JH, et al. A multicenter investigation of fixed‐dose fluoxetine in the treatment of obsessive‐compulsive disorder. Arch Gen Psychiatry 1994; 51: 559 – 67.en_US
dc.identifier.citedreferenceKaye WH, Weltzin TE, Hsu LK, Bulik CM. An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry 1991; 52: 464 – 71.en_US
dc.identifier.citedreferenceLevine LR, Enas GG, Thompson WL, et al. Use of fluoxetine, a selective serotonin‐uptake inhibitor, in the treatment of obesity: a dose‐response study. Int J Obesity 1989; 13: 635 – 45.en_US
dc.identifier.citedreferenceFluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo‐controlled, double‐blind trial. Arch Gen Psychiatry 1992; 49: 139 – 47.en_US
dc.identifier.citedreferenceBystritsky A, Rosen RM, Murphy KJ, Bohn P, Keys SA, Vapnik T. Double‐blind pilot trial of desipramine versus fluoxetine in panic patients. Anxiety 199495; 1: 287 – 90.en_US
dc.identifier.citedreferenceZoeller J. The top 200 drugs. Am Druggist 1997; 214: 30 – 7.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1875-9114.1998.tb03908.x.pdf
Size:
419.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.